Experiences of coordinated care for people in the UK affected by rare diseases: cross-sectional survey of patients, carers, and healthcare professionals

Author:

Walton HollyORCID,Ng Pei LiORCID,Simpson AmyORCID,Bloom LaraORCID,Chitty Lyn S.ORCID,Fulop Naomi J.ORCID,Hunter AmyORCID,Jones JenniferORCID,Kai JoeORCID,Kerecuk LarissaORCID,Kokocinska MariaORCID,Leeson-Beevers KerryORCID,Parkes SharonORCID,Ramsay Angus I. G.ORCID,Sutcliffe AlastairORCID,Taylor ChristineORCID,Morris StephenORCID

Abstract

Abstract Background Poorly coordinated care can have major impacts on patients and families affected by rare conditions, with negative physical health, psychosocial and financial consequences. This study aimed to understand how care is coordinated for rare diseases in the United Kingdom. Methods We undertook a national survey in the UK involving 760 adults affected by rare diseases, 446 parents/carers of people affected by rare diseases, and 251 healthcare professionals who care for people affected by rare diseases. Results Findings suggested that a wide range of patients, parents and carers do not have coordinated care. For example, few participants reported having a care coordinator (12% patients, 14% parents/carers), attending a specialist centre (32% patients, 33% parents/carers) or having a care plan (10% patients, 44% parents/carers). A very small number of patients (2%) and parents/carers (5%) had access to all three—a care coordinator, specialist centre and care plan. Fifty four percent of patients and 33% of parents/carers reported access to none of these. On the other hand, a higher proportion of healthcare professionals reported that families with rare conditions had access to care coordinators (35%), specialist centres (60%) and care plans (40%). Conclusions Care for families with rare conditions is generally not well coordinated in the UK, with findings indicating limited access to care coordinators, specialist centres and care plans. Better understanding of these issues can inform how care coordination might be improved and embrace the needs and preferences of patients and families affected by rare conditions.

Funder

Health Services and Delivery Research Programme

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics (clinical),General Medicine

Reference33 articles.

1. Rare Disease UK. What is a Rare Disease? www.raredisease.org.uk/what-is-a-rare-disease/. Accessed 17 Jan 2021.

2. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28:165–73. https://doi.org/10.1038/s41431-019-0508-0.

3. European Commission. EU Research on Rare Diseases. https://ec.europa.eu/info/researchand-innovation/research-area/health-research-and-innovation/rare-diseases_en. Accessed 17 Jan 2021.

4. Walton H, Hudson ME, Simpson A, Ramsay AI, Kai J, Morris S, Sutcliffe AG, Fulop NJ. Defining coordinated care for people with rare conditions: a scoping review. Int J Integr Care. 2020;20(2):14.

5. Rare Disease UK. The rare reality—an insight into the patient and family experience of rare disease. 2016. www.raredisease.org.uk/media/2361/patient-experiences-2015.pdf. Accessed 22 Oct 2021.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3